Annual EBIT
-$46.69 M
-$13.15 M-39.21%
December 31, 2023
Summary
- As of February 12, 2025, SCPH annual earnings before interest & taxes is -$46.69 million, with the most recent change of -$13.15 million (-39.21%) on December 31, 2023.
- During the last 3 years, SCPH annual EBIT has fallen by -$17.07 million (-57.61%).
- SCPH annual EBIT is now -343.88% below its all-time high of -$10.52 million, reached on December 31, 2015.
Performance
SCPH EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$33.26 M
-$18.30 M-122.35%
September 30, 2024
Summary
- As of February 12, 2025, SCPH quarterly earnings before interest & taxes is -$33.26 million, with the most recent change of -$18.30 million (-122.35%) on September 30, 2024.
- Over the past year, SCPH quarterly EBIT has dropped by -$21.54 million (-183.75%).
- SCPH quarterly EBIT is now -746.40% below its all-time high of -$3.93 million, reached on December 31, 2016.
Performance
SCPH Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$71.94 M
-$19.68 M-37.66%
September 30, 2024
Summary
- As of February 12, 2025, SCPH TTM earnings before interest & taxes is -$71.94 million, with the most recent change of -$19.68 million (-37.66%) on September 30, 2024.
- Over the past year, SCPH TTM EBIT has dropped by -$25.25 million (-54.09%).
- SCPH TTM EBIT is now -1730.95% below its all-time high of -$3.93 million, reached on December 31, 2016.
Performance
SCPH TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SCPH EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.2% | -183.8% | -54.1% |
| 3 y3 years | -57.6% | -356.2% | -114.5% |
| 5 y5 years | -66.7% | -356.2% | -114.5% |
SCPH EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -83.4% | at low | -396.6% | at low | -182.6% | at low |
| 5 y | 5-year | -83.4% | at low | -465.1% | at low | -182.6% | at low |
| alltime | all time | -343.9% | at low | -746.4% | at low | -1731.0% | at low |
ScPharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$33.26 M(+122.4%) | -$71.94 M(+37.7%) |
| Jun 2024 | - | -$14.96 M(+24.6%) | -$52.26 M(+5.7%) |
| Mar 2024 | - | -$12.01 M(+2.4%) | -$49.45 M(+5.9%) |
| Dec 2023 | -$46.69 M(+39.2%) | -$11.72 M(-13.7%) | -$46.69 M(+10.5%) |
| Sep 2023 | - | -$13.57 M(+11.8%) | -$42.26 M(+9.9%) |
| Jun 2023 | - | -$12.14 M(+31.3%) | -$38.47 M(+8.1%) |
| Mar 2023 | - | -$9.25 M(+26.9%) | -$35.57 M(+6.1%) |
| Dec 2022 | -$33.54 M(+31.7%) | -$7.29 M(-25.5%) | -$33.54 M(+1.8%) |
| Sep 2022 | - | -$9.79 M(+5.8%) | -$32.95 M(+13.4%) |
| Jun 2022 | - | -$9.25 M(+28.2%) | -$29.05 M(+10.8%) |
| Mar 2022 | - | -$7.21 M(+7.7%) | -$26.21 M(+2.9%) |
| Dec 2021 | -$25.46 M(-14.1%) | -$6.70 M(+13.8%) | -$25.46 M(-1.7%) |
| Sep 2021 | - | -$5.88 M(-8.2%) | -$25.89 M(-8.8%) |
| Jun 2021 | - | -$6.41 M(-0.9%) | -$28.39 M(-4.2%) |
| Mar 2021 | - | -$6.47 M(-9.3%) | -$29.63 M(+0.0%) |
| Dec 2020 | -$29.62 M | -$7.13 M(-15.0%) | -$29.62 M(-9.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$8.38 M(+9.5%) | -$32.66 M(+8.6%) |
| Jun 2020 | - | -$7.66 M(+18.6%) | -$30.09 M(+2.6%) |
| Mar 2020 | - | -$6.46 M(-36.5%) | -$29.32 M(-6.1%) |
| Dec 2019 | -$31.23 M(+11.5%) | -$10.17 M(+75.0%) | -$31.23 M(+21.1%) |
| Sep 2019 | - | -$5.81 M(-15.6%) | -$25.79 M(+1.6%) |
| Jun 2019 | - | -$6.89 M(-17.7%) | -$25.38 M(-9.3%) |
| Mar 2019 | - | -$8.37 M(+76.8%) | -$27.99 M(-0.1%) |
| Dec 2018 | -$28.01 M(+21.7%) | -$4.73 M(-12.4%) | -$28.01 M(-6.1%) |
| Sep 2018 | - | -$5.40 M(-43.1%) | -$29.83 M(+0.8%) |
| Jun 2018 | - | -$9.49 M(+13.1%) | -$29.59 M(+11.6%) |
| Mar 2018 | - | -$8.39 M(+28.2%) | -$26.50 M(+15.1%) |
| Dec 2017 | -$23.02 M(+28.9%) | -$6.54 M(+26.8%) | -$23.02 M(+12.8%) |
| Sep 2017 | - | -$5.16 M(-19.4%) | -$20.41 M(+33.8%) |
| Jun 2017 | - | -$6.40 M(+30.4%) | -$15.24 M(+72.4%) |
| Mar 2017 | - | -$4.91 M(+25.0%) | -$8.84 M(+125.0%) |
| Dec 2016 | -$17.86 M(+69.9%) | -$3.93 M | -$3.93 M |
| Dec 2015 | -$10.52 M | - | - |
FAQ
- What is scPharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for scPharmaceuticals?
- What is scPharmaceuticals annual EBIT year-on-year change?
- What is scPharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for scPharmaceuticals?
- What is scPharmaceuticals quarterly EBIT year-on-year change?
- What is scPharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for scPharmaceuticals?
- What is scPharmaceuticals TTM EBIT year-on-year change?
What is scPharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of SCPH is -$46.69 M
What is the all time high annual EBIT for scPharmaceuticals?
scPharmaceuticals all-time high annual earnings before interest & taxes is -$10.52 M
What is scPharmaceuticals annual EBIT year-on-year change?
Over the past year, SCPH annual earnings before interest & taxes has changed by -$13.15 M (-39.21%)
What is scPharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of SCPH is -$33.26 M
What is the all time high quarterly EBIT for scPharmaceuticals?
scPharmaceuticals all-time high quarterly earnings before interest & taxes is -$3.93 M
What is scPharmaceuticals quarterly EBIT year-on-year change?
Over the past year, SCPH quarterly earnings before interest & taxes has changed by -$21.54 M (-183.75%)
What is scPharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of SCPH is -$71.94 M
What is the all time high TTM EBIT for scPharmaceuticals?
scPharmaceuticals all-time high TTM earnings before interest & taxes is -$3.93 M
What is scPharmaceuticals TTM EBIT year-on-year change?
Over the past year, SCPH TTM earnings before interest & taxes has changed by -$25.25 M (-54.09%)